Latarjet Procedure vs Anatomic Glenoid Reconstruction for Shoulder Dislocation
Trial Summary
What is the purpose of this trial?
This trial compares two surgeries for stabilizing shoulders that frequently dislocate due to bone loss. One method moves a piece of bone and tendon, while the other uses a donor bone graft. The goal is to see which method is safer and more effective.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Anatomic Glenoid Reconstruction for shoulder dislocation?
The Latarjet procedure, which is similar to Anatomic Glenoid Reconstruction, has shown excellent results in treating shoulder dislocations, with 68% of cases rated as excellent and 21.7% as good after an 8-year follow-up. Additionally, the Anatomic Glenoid Reconstruction using distal tibial allograft has shown excellent short-term results with minimal complications, indicating its potential effectiveness.12345
Is the Latarjet procedure or Anatomic Glenoid Reconstruction generally safe for humans?
The Latarjet procedure and Anatomic Glenoid Reconstruction have been shown to have minimal complication rates and are considered safe for treating shoulder instability. Studies report excellent short-term results with these procedures, and they are often used when other treatments fail, with a low risk of complications like neurovascular injuries.13678
How does the Anatomic Glenoid Reconstruction treatment differ from other treatments for shoulder dislocation?
Anatomic Glenoid Reconstruction is unique because it uses an arthroscopic technique to insert a distal tibial allograft (a bone graft from a donor) through a novel portal, offering an alternative to the more invasive open Latarjet procedure. This approach aims to address glenoid bone loss while potentially reducing the technical challenges and complications associated with traditional methods.125910
Research Team
Ivan Wong, MD
Principal Investigator
Nova Scotia Health Authority, Orthopaedic Surgeon
Eligibility Criteria
This trial is for individuals who have experienced one or more anterior shoulder dislocations and show over 20% bone loss on a pre-operative CT scan. It's not suitable for those with posterior or multidirectional instability, massive rotator cuff tears, substance abuse history, or inability to consent or accept random treatment assignment.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either the Latarjet or Anatomic Glenoid Reconstruction surgical procedure to address anterior shoulder instability with glenoid bone loss
Follow-up
Participants are monitored for safety, complications, and effectiveness of the surgical intervention through clinical and radiographic outcome measures
Long-term follow-up
Participants continue to be monitored for recurrent instability and other long-term outcomes
Treatment Details
Interventions
- Anatomic Glenoid Reconstruction
- Latarjet
Anatomic Glenoid Reconstruction is already approved in European Union, United States for the following indications:
- Anterior shoulder instability
- Glenoid bone loss
- Recurrent shoulder dislocations
- Glenoid bone loss
Find a Clinic Near You
Who Is Running the Clinical Trial?
Nova Scotia Health Authority
Lead Sponsor